/ C O R R E C T I O N -- Gesynta Pharma/
Published on 03/20/2026 at 09:52 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat-302711084.html
en | boerse | 68934886 |
